Etimicin is a fourth-generation semisynthetic aminoglycoside antibiotic derived from gentamicin C1a, widely recognized for its broad-spectrum antibacterial activity against both gram-negative and gram-positive… Read more
Etimicin is a fourth-generation semisynthetic aminoglycoside antibiotic derived from gentamicin C1a, widely recognized for its broad-spectrum antibacterial activity against both gram-negative and gram-positive bacteria. By inhibiting bacterial protein synthesis, this therapeutic agent serves as a critical treatment option for various infections, including those involving resistant strains. This category provides a comprehensive selection of high-quality reference standards, including the parent API, pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories during impurity profiling, method development, and validation studies. By utilizing these precise analytical standards, researchers and quality control professionals can ensure the accuracy of their testing procedures, monitor potential degradation pathways, and verify the overall purity and efficacy of etimicin formulations in compliance with rigorous regulatory requirements.